Clinical trials
Phase 2/3 Hematologic Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2019 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 3 |
| Completed | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Emory University | 1 |
| Fred Hutchinson Cancer Center | 1 |
| Gamida Cell -Teva Joint Venture Ltd. | 1 |
| Kiadis Pharma | 1 |
| Masonic Cancer Center, University of Minnesota | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Neoplasms | 5 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Myelodysplastic Syndromes | 2 |
| Graft vs Host Disease | 1 |
| Hodgkin Disease | 1 |
| Leukemia, Lymphoid | 1 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 |
| Leukemia, Myeloid | 1 |
| Leukemia, Myeloid, Acute | 1 |
| Lymphoma | 1 |
Trials
Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.